Development of lysosomal storage in mice with targeted disruption of the β-galactosidase gene: a model of human GM1-gangliosidosis

This publication has 12 references indexed in Scilit:

• The Degradative Pathway of Gangliosides GM1 and GM2 in Neuro2a Cells by Sialidase
  Journal of Neurochemistry, 2002
• Mouse Models of Human Lysosomal Diseases
  Brain Pathology, 1998
• Generalized CNS Disease and Massive GM1-Ganglioside Accumulation in Mice Defective in Lysosomal Acid -galactosidase
  Human Molecular Genetics, 1997
• Neurological manifestations of knockout mice with β-galactosidase deficiency
  Brain & Development, 1997
• β-Galactosidase-deficient mouse as an animal model for GM1-gangliosidosis
  Glycoconjugate Journal, 1997
• Developmental changes of ganglioside expressions in postnatal rat cerebellar cortex
  Brain Research, 1995
• Mouse models of Tay–Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism
  Nature Genetics, 1995
• Neuropathology of mice with targeted disruption of Hexa gene, a model of Tay-Sachs disease
  Acta Neuropathologica, 1995
• Pathologic Findings in Fetal GM1 Gangliosidosis
  Archives of Neurology, 1986
• GM1-gangliosidosis: Chromosome 3 assignment of the?-galactosidase-A gene (? GAL A )
  Somatic Cell and Molecular Genetics, 1979